Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracameral lidocaine in cataract surgery
IRCT20200825048515N16Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lidocaine in cataract (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Pain score, Heart rate and 2 more. Started Dec 2020; status: completed.
02
Drugs
lidocaine
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20200825048515N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N16.